Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Taisho researchers reveal cGMP-dependent phosphodiesterase (PDE V) inhibitors

May 31, 1996

Phase II clinical trial on Gensia's second-generation adenosine-regulating agent commence

May 31, 1996

Gene transfer as treatment for myocardial ischemia

May 31, 1996

Valsartan approved in Germany

May 31, 1996

Endothelin antagonists revealed by Fujisawa

May 31, 1996

FDA to discuss ProAmatine application

May 24, 1996

Na+/K+-ATPase inhibitors disclosed by Sigma-Tau

May 24, 1996

Medco, Fujisawa to codevelop and comarket adenosine for CABG and AMI

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Update on fenoldopam regulatory submission

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 9, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave
BioWorld MedTech
Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...